Destiny Pharma plc
DEST.L · LSE
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£5,657 | -£6,504 | -£5,339 | -£5,411 |
| Dep. & Amort. | £6 | £12 | £13 | £17 |
| Deferred Tax | £0 | -£544 | -£233 | -£553 |
| Stock-Based Comp. | £475 | £534 | £406 | £139 |
| Change in WC | -£428 | £411 | -£296 | £91 |
| Other Non-Cash | £933 | £263 | £375 | £296 |
| Operating Cash Flow | -£5,185 | -£5,827 | -£5,075 | -£5,421 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£81 | -£1 | -£30 | -£2,264 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £210 | £65 | £16 | -£2,190 |
| Investing Cash Flow | -£81 | -£1 | -£30 | -£2,264 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £0 | £0 | £0 |
| Stock Issued | £6,745 | £6,086 | £7 | £9,949 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £0 | £0 | £0 | £0 |
| Financing Cash Flow | £6,745 | £6,086 | £7 | £9,949 |
| Forex Effect | £0 | £0 | £0 | £0 |
| Net Chg. in Cash | £1,479 | £258 | -£5,099 | £2,265 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £4,903 | £4,646 | £9,744 | £7,480 |
| End Cash | £6,383 | £4,903 | £4,646 | £9,744 |
| Free Cash Flow | -£5,266 | -£5,829 | -£5,105 | -£7,684 |